Biomedical uses of lithium

· GRIN Verlag
4.0
1 āŠ°āŠŋāŠĩāŦāŠŊāŦ‚
āŠ‡-āŠŠāŦāŠļāŦāŠĪāŠ•
29
āŠŠāŦ‡āМ
āŠŠāŠūāŠĪāŦāа
āŠ°āŦ‡āПāŠŋāŠ‚āŠ— āŠ…āŠĻāŦ‡ āŠ°āŠŋāŠĩāŦāŠŊāŦ‚ āŠšāŠ•āŠūāŠļāŦ‡āŠēāŠū āŠĻāŠĨāŦ€Â āŠĩāŠ§āŦ āŠœāŠūāŠĢāŦ‹

āŠ† āŠ‡-āŠŠāŦāŠļāŦāŠĪāŠ• āŠĩāŠŋāŠķāŦ‡

Studienarbeit aus dem Jahr 2012 im Fachbereich Medizin - Biomedizinische Technik, University Of Abuja, Sprache: Deutsch, Abstract: Biomedical uses of Lithium refer to use of the lithium ion, Li+, as a drug. A number of chemical salts of lithium are used medically as mood-stabilizing drugs, primarily in the treatment of bipolar disorder, where they have a role in the treatment of depression and particularly of mania, both acutely and in the long term. As a mood stabilizer, lithium is probably more effective in preventing mania than depression, and reduces the risk of suicide in bipolar patients.(Baldessarini et al, 2006) In depression alone (unipolar disorder), lithium can be used to augment other antidepressants . Lithium carbonates (Li2CO3), sold under several trade names, is the most commonly prescribed, while lithium citrate (Li3C6H5O7) is also used in conventional pharmacological treatments. Lithium sulfate (Li2SO4) has been presented as an alternative[citation needed]. Lithium orotate is sometimes marketed as a "safe" natural alternative with fewer side effects than conventional lithium, yet caution must be taken with all of the active lithium salts. Upon ingestion, lithium becomes widely distributed in the central nervous system and interacts with a number of neurotransmitters and receptors, decreasing norepinephrine release and increasing serotonin synthesis.

āŠ°āŦ‡āПāŠŋāŠ‚āŠ— āŠ…āŠĻāŦ‡ āŠ°āŠŋāŠĩāŦāŠŊāŦ‚

4.0
1 āŠ°āŠŋāŠĩāŦāŠŊāŦ‚

āŠ† āŠ‡-āŠŠāŦāŠļāŦāŠĪāŠ•āŠĻāŦ‡ āŠ°āŦ‡āПāŠŋāŠ‚āŠ— āŠ†āŠŠāŦ‹

āŠĪāŠŪāŦ‡ āŠķāŦāŠ‚ āŠĩāŠŋāŠšāŠūāŠ°āŦ‹ āŠ›āŦ‹ āŠ…āŠŪāŠĻāŦ‡ āŠœāŠĢāŠūāŠĩāŦ‹.

āŠŪāŠūāŠđāŠŋāŠĪāŦ€ āŠĩāŠūāŠ‚āŠšāŠĩāŦ€

āŠļāŦāŠŪāŠūāŠ°āŦāПāŠŦāŦ‹āŠĻ āŠ…āŠĻāŦ‡ āŠŸāŦ…āŠŽāŦāŠēāŦ‡āП
Android āŠ…āŠĻāŦ‡ iPad/iPhone āŠŪāŠūāŠŸāŦ‡ Google Play Books āŠāŠŠ āŠ‡āŠĻāŦāŠļāŦāПāŦ‰āŠē āŠ•āŠ°āŦ‹. āŠĪāŦ‡ āŠĪāŠŪāŠūāŠ°āŠū āŠāŠ•āŠūāŠ‰āŠĻāŦāП āŠļāŠūāŠĨāŦ‡ āŠ‘āŠŸāŦ‹āŠŪāŦ…āПāŠŋāŠ• āŠ°āŦ€āŠĪāŦ‡ āŠļāŠŋāŠ‚āŠ• āŠĨāŠūāŠŊ āŠ›āŦ‡ āŠ…āŠĻāŦ‡ āŠĪāŠŪāŠĻāŦ‡ āŠœāŦāŠŊāŠūāŠ‚ āŠŠāŠĢ āŠđāŦ‹ āŠĪāŦāŠŊāŠūāŠ‚ āŠĪāŠŪāŠĻāŦ‡ āŠ‘āŠĻāŠēāŠūāŠ‡āŠĻ āŠ…āŠĨāŠĩāŠū āŠ‘āŠŦāŠēāŠūāŠ‡āŠĻ āŠĩāŠūāŠ‚āŠšāŠĩāŠūāŠĻāŦ€ āŠŪāŠ‚āŠœāŦ‚āаāŦ€ āŠ†āŠŠāŦ‡ āŠ›āŦ‡.
āŠēāŦ…āŠŠāŠŸāŦ‰āŠŠ āŠ…āŠĻāŦ‡ āŠ•āŠŪāŦāŠŠāŦāŠŊāŦāŠŸāŠ°
Google Play āŠŠāŠ° āŠ–āŠ°āŦ€āŠĶāŦ‡āŠē āŠ‘āŠĄāŠŋāŠ“āŠŽāŦāŠ•āŠĻāŦ‡ āŠĪāŠŪāŦ‡ āŠĪāŠŪāŠūāŠ°āŠū āŠ•āŠŪāŦāŠŠāŦāŠŊāŦāŠŸāŠ°āŠĻāŠū āŠĩāŦ‡āŠŽ āŠŽāŦāаāŠūāŠ‰āŠāŠ°āŠĻāŦ‹ āŠ‰āŠŠāŠŊāŦ‹āŠ— āŠ•āŠ°āŦ€āŠĻāŦ‡ āŠļāŠūāŠ‚āŠ­āŠģāŦ€ āŠķāŠ•āŦ‹ āŠ›āŦ‹.
eReaders āŠ…āŠĻāŦ‡ āŠ…āŠĻāŦāŠŊ āŠĄāŠŋāŠĩāŠūāŠ‡āŠļ
Kobo āŠ‡-āŠ°āŦ€āŠĄāŠ° āŠœāŦ‡āŠĩāŠū āŠ‡-āŠ‡āŠ‚āŠ• āŠĄāŠŋāŠĩāŠūāŠ‡āŠļ āŠŠāŠ° āŠĩāŠūāŠ‚āŠšāŠĩāŠū āŠŪāŠūāŠŸāŦ‡, āŠĪāŠŪāŠūāŠ°āŦ‡ āŠŦāŠūāŠ‡āŠēāŠĻāŦ‡ āŠĄāŠūāŠ‰āŠĻāŠēāŦ‹āŠĄ āŠ•āŠ°āŦ€āŠĻāŦ‡ āŠĪāŠŪāŠūāŠ°āŠū āŠĄāŠŋāŠĩāŠūāŠ‡āŠļ āŠŠāŠ° āŠŸāŦāаāŠūāŠĻāŦāŠļāŠŦāŠ° āŠ•āŠ°āŠĩāŠūāŠĻāŦ€ āŠœāŠ°āŦ‚āа āŠŠāŠĄāŠķāŦ‡. āŠļāŠŠāŦ‹āаāŦāПāŦ‡āŠĄ āŠ‡-āŠ°āŦ€āŠĄāŠ° āŠŠāŠ° āŠŦāŠūāŠ‡āŠēāŦ‹ āŠŸāŦāаāŠūāŠĻāŦāŠļāŦāŠŦāŠ° āŠ•āŠ°āŠĩāŠū āŠŪāŠūāŠŸāŦ‡ āŠļāŠđāŠūāŠŊāŠĪāŠū āŠ•āŦ‡āŠĻāŦāŠĶāŦāаāŠĻāŦ€ āŠĩāŠŋāŠ—āŠĪāŠĩāŠūāŠ° āŠļāŦ‚āКāŠĻāŠūāŠ“ āŠ…āŠĻāŦāŠļāŠ°āŦ‹.